Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population
Theyre asking because they want to know: Whether direct lung delivery makes sense when oral support hasnt felt specific enough Whether it fits mold or post-viral recovery , where airway inflammation can linger Whether it belongs in a broader plan , rather than being treated like a stand-alone fix Clinical perspective: In naturopathic care, targeted therapies matter most when they match the pattern in front of you
PTSD-related neuroimaging abnormalities in brain function, structure, and biochemistry
Its Time to Evolve Come in for an appointment, so we can understand your specific concerns and create a treatment plan
The emerging world of the fungal microbiome
10.1080/02713683.2018.1484143 Curr
